Search

everythinglearnresearchcommunity

for

Search:↓

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

Dutasteride's effect on hair loss treatment is uncertain and should be used cautiously.

Dutasteride is linked to a higher chance of sexual dysfunction, especially in younger males and the elderly.

More men are using medication for benign prostatic hyperplasia, influenced by marketing and FDA approvals.

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Testosterone with dutasteride improves muscle strength and body composition in trans men.

BPH treatments can cause sexual side effects affecting quality of life.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

The combination of cyproterone acetate and testosterone enanthate is highly effective in preventing sperm production and could be a good reversible male contraceptive.

Alfuzosin reduces short-term surgery need after catheter removal, but long-term benefits are unclear; combination therapy may help prevent urinary issues.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Dutasteride safely treats hair loss without harming sexual function.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Cyproterone acetate effectively treats sexual disorders by reducing sexual functions and is generally well-tolerated.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

The inhibitor affects androgen metabolism but not ovarian function.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Dutasteride is more effective than finasteride for hair loss but may affect male fertility and should be used cautiously.

Dutasteride is more effective than finasteride for hair loss, but more research is needed on safety and dosing.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

Dutasteride reduces prostate cancer risk by 23% in high-risk men.

Taking dutasteride for one month before prostate surgery can reduce bleeding.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.